Medicores Homoeopathic Laboratory Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
as on 21-12-2024
- Paid Up Capital ₹ 0.50 M
as on 21-12-2024
- Company Age 16 Year, 2 Months
- Last Filing with ROC 31 Mar 2022
- Revenue 10.65%
(FY 2020)
- Profit 88.24%
(FY 2020)
- Ebitda 9.37%
(FY 2020)
- Net Worth 19.18%
(FY 2020)
- Total Assets -7.51%
(FY 2020)
About Medicores Homoeopathic Laboratory
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2022. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.50 M, as per Ministry of Corporate Affairs (MCA) records.
Rakesh Kumar, Rahul Kumar, Rinku Kumari, and Three other members serve as directors at the Company.
- CIN/LLPIN
U24232DL2008PTC184238
- Company No.
184238
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
14 Oct 2008
- Date of AGM
30 Sep 2022
- Date of Balance Sheet
31 Mar 2022
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Delhi, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Medicores Homoeopathic Laboratory?
Board Members(6)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Rakesh Kumar  | Director | 14-Oct-2008 | Current |
| Rahul Kumar | Director | 14-Oct-2008 | Current |
| Rinku Kumari | Director | 14-Oct-2008 | Current |
| Rishabh Raj | Whole-Time Director | 30-Nov-2021 | Current |
| Saurabh Raj | Whole-Time Director | 30-Nov-2021 | Current |
| Saroj Singh | Director | 14-Oct-2008 | Current |
Financial Performance of Medicores Homoeopathic Laboratory.
Medicores Homoeopathic Laboratory Private Limited, for the financial year ended 2020, experienced significant growth in revenue, with a 10.65% increase. The company also saw a substantial improvement in profitability, with a 88.24% increase in profit. The company's net worth Soared by an impressive increase of 19.18%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Medicores Homoeopathic Laboratory?
In 2020, Medicores Homoeopathic Laboratory had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Medicores Homoeopathic Laboratory?
Unlock and access historical data on people associated with Medicores Homoeopathic Laboratory, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Medicores Homoeopathic Laboratory, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Medicores Homoeopathic Laboratory's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
